Literature DB >> 4033326

High-grade malignancies of the parotid gland: effective use of planned combined surgery and irradiation.

H M Matsuba, S E Thawley, V R Devineni, L A Levine, P G Smith.   

Abstract

The trend toward treatment of parotid gland malignancies with planned combined surgery and postoperative radiation therapy is currently being followed by many centers, although prospective studies confirming the efficacy of this treatment regimen have only recently begun. We have reviewed only our "high-grade" histologic types: adenocarcinomas, malignant mixed tumors, high-grade mucoepidermoid carcinomas, squamous cell carcinomas, and undifferentiated carcinomas. Acinic cell carcinomas, adenoid cystic carcinomas, and low-grade mucoepidermoid carcinomas were excluded from study because of their different biologic behavior. Since 1974, we have employed the approach of surgical extirpation with preservation of the facial nerve when possible for all parotid tumors, combined with planned postoperative radiation therapy (50-70 Gy). We reviewed the 37 cases of "high-grade" parotid gland malignancies and compared the patients treated with the combined modality approach with our historical patients treated initially with surgery alone. Despite an apparent higher stage at presentation, our combined treatment group ultimately had significantly better local control (70% vs. 20%), and an equivalent survival rate at five years. Tumor was present at the margin of resection in 14 (74%) cases treated with combined surgery and irradiation. The facial nerve was preserved in six of these patients with positive margins, and only one of these patients developed a local or regional treatment failure. In conclusion, our data confirms the efficacy of surgical exploration to determine the extent of disease and surgical resection, preserving facial nerve function if possible, followed by postoperative radiation therapy at adequate doses. Control of local-regional disease was much improved by combined modality therapy as opposed to surgical resection alone, despite the prevalence of residual microscopic disease in the resection margins. Facial nerve function is optimally preserved by this approach of conservative surgery combined with postoperative radiation therapy.

Entities:  

Mesh:

Year:  1985        PMID: 4033326

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Intratemporal Grafting of the Facial Nerve following Lateral Skull Base Tumor Resection.

Authors:  John P Leonetti; Douglas E Anderson; Sam J Marzo; Thomas C Origitano; Guy J Petruzzelli
Journal:  Skull Base       Date:  2007-05

2.  Risk of nodal metastases from malignant salivary gland tumors related to tumor size and grade of malignancy.

Authors:  S Rodríguez-Cuevas; S Labastida; L Baena; F Gallegos
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

3.  Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004).

Authors:  Christopher M Nutting; James P Morden; Matthew Beasley; Shreerang Bhide; Audrey Cook; Emma De Winton; Marie Emson; Mererid Evans; Lydia Fresco; Simon Gollins; Dorothy Gujral; Kevin Harrington; Mano Joseph; Catherine Lemon; Linda Luxon; Qurrat van den Blink; Ruheena Mendes; Aisha Miah; Kate Newbold; Robin Prestwich; Martin Robinson; Paul Sanghera; Joanna Simpson; Muthiah Sivaramalingam; Narayanan Nair Srihari; Mark Sydenham; Emma Wells; Stephanie Witts; Emma Hall
Journal:  Eur J Cancer       Date:  2018-10-01       Impact factor: 9.162

4.  [Correlation between magnetic resonance imaging and extemporaneous and definitive histological examination of parotid gland tumors: a case series].

Authors:  Najib Zouhair; Sanaa Mallouk; Youssef Oukessou; Sami Rouadi; Redallah Larbi Abada; Mohamed Roubal; Mohamed Mahtar
Journal:  Pan Afr Med J       Date:  2020-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.